Carl Zeiss Meditec AG represents values of innovation, precision, and excellence in the field of medical technology. The company's corporate philosophy is centered around providing cutting-edge solutions for ophthalmology and microsurgery, enabling professionals to deliver exceptional patient care. With a focus on research and development, Carl Zeiss Meditec AG continuously seeks to advance medical technology by integrating optics and digital systems. Their commitment to high-quality products and services has made them a global leader in the industry, trusted by healthcare professionals worldwide. Carl Zeiss Meditec AG upholds a strong sense of responsibility towards their customers, employees, and the environment, ensuring sustainable and ethical practices in all aspects of their operations.

Carl Zeiss Meditec AG is primarily present in various countries and regions around the world. Some of the key regions where the company operates include Europe, North America, Asia-Pacific, and Latin America. With its headquarters in Germany, Carl Zeiss Meditec AG has established a strong presence in numerous European countries such as France, Italy, Spain, and the United Kingdom. Additionally, the company has a significant market presence in the United States, Canada, China, Japan, South Korea, and Australia among others. Overall, Carl Zeiss Meditec AG has a global footprint, enabling it to serve a wide range of markets and customers worldwide.

Carl Zeiss Meditec AG has achieved several significant milestones since its inception. The company has established itself as a leading provider of innovative medical technology solutions for ophthalmology and microsurgery. One major achievement is the development and production of advanced diagnostic and surgical equipment, including optical coherence tomography (OCT) systems and intraocular lenses (IOLs). Carl Zeiss Meditec AG has also expanded its global presence through strategic partnerships, acquisitions, and collaborations. Additionally, the company has received numerous awards and recognitions for its contributions to the healthcare industry. Overall, Carl Zeiss Meditec AG continues to excel in delivering cutting-edge solutions and improving patient outcomes in the field of medical technology.

Carl Zeiss Meditec AG is a renowned medical technology company that specializes in innovating and manufacturing ophthalmic devices. Founded in 2002, it is a subsidiary of Carl Zeiss AG, a global leader in optical and optoelectronic industries established in 1846. Carl Zeiss Meditec AG is headquartered in Germany and operates worldwide through its subsidiaries and distribution network. The company focuses on developing state-of-the-art equipment for diagnosing and treating eye conditions, such as lasers, microscopes, and optical coherence tomography systems. With a steadfast commitment to advancing healthcare, Carl Zeiss Meditec AG continues to contribute significantly to the ophthalmic industry's progress and patient care worldwide.

The main competitors of Carl Zeiss Meditec AG in the market are Alcon, Topcon Corporation, Johnson & Johnson Vision Care, Bausch Health Companies, and NIDEK Co., Ltd.

Carl Zeiss Meditec AG primarily operates in the medical technology industry.

The business model of Carl Zeiss Meditec AG revolves around providing innovative medical technology solutions in the field of ophthalmology. As one of the leading companies in the industry, Carl Zeiss Meditec offers a wide range of products and services including surgical microscopes, diagnostic devices, and solutions for ophthalmic surgeries. By combining cutting-edge technology with extensive expertise, the company aims to improve the quality of patient care and enhance ophthalmic treatments. With a focus on research and development, Carl Zeiss Meditec continues to deliver state-of-the-art solutions to meet the evolving needs of ophthalmologists and patients worldwide.

مُعامل القيمة السوقية إلى الأرباح لـ Carl Zeiss Meditec هو ٣١٫١١.

مُعامِل القيمة إلى المبيعات Carl Zeiss Meditec هو ٢٫٧٠.

نقاط جودة AlleAktien لـ Carl Zeiss Meditec هي 7/10.

المتوقعة Carl Zeiss Meditec الإيرادات هي ٢٫١٠ مليارات EUR.

صافي الربح المتوقعة Carl Zeiss Meditec هو ١٨٢٫٢٨ مليون. EUR.

Carl Zeiss Meditec AG is a globally leading company in the field of medical technology, offering innovative solutions for diagnostics and therapy. It specializes in the development, production, and distribution of medical devices, providing a wide range of products and services to its customers. The company's main divisions include ophthalmology, neurology, oncology, and dental medicine. Its business model focuses on advanced technology, innovation, and quality, with continuous investment in research and development. The company collaborates with leading hospitals and universities worldwide to improve its products and develop new applications for medical devices. It also has an effective marketing strategy to create brand awareness and customer loyalty, working with a network of distribution partners to sell its products globally. Through comprehensive training and support programs, Carl Zeiss Meditec AG ensures the effective and safe use of its products. Overall, it is a leading provider of medical technology, offering advanced and innovative solutions for the diagnosis and therapy of medical conditions.

يوزع Carl Zeiss Meditec أرباحًا قدرها ٠٫٩٠ EUR من خلال 1 عمليات توزيع موزعة على مدار السنة.

Carl Zeiss Meditec يوزع أرباحًا 1 مرة في السنة.

الرمز الدولي للأوراق المالية الخاص بـCarl Zeiss Meditec هو DE0005313704.

رمز WKN لـ Carl Zeiss Meditec هو 531370.

الرمز المُختصر لـ Carl Zeiss Meditec هو AFX.DE.

خلال آخر 12 شهراً، دفعت Carl Zeiss Meditec توزيعات أرباح بقيمة ١٫١٠ EUR . وهذا يعادل عائد توزيعات أرباح يقارب ١٫٧٤ %. ومن المتوقع أن تدفع Carl Zeiss Meditec خلال الـ12 شهراً القادمة توزيعات أرباح تقدر بـ١٫٢٢ EUR.

نسبة توزيعات الأرباح الحالية لـ Carl Zeiss Meditec هي ١٫٧٤ %.

Carl Zeiss Meditec يدفع توزيعات أرباح ربع سنوية. يتم توزيعها في الأشهر أبريل, أبريل, أبريل, أبريل.

Carl Zeiss Meditec دفعت توزيعات الأرباح كل عام خلال الـ20 سنوات الماضية.

يُتوقع خلال الـ12 شهرًا القادمة توزيع أرباح بقيمة ١٫٢٢ EUR. وهذا يعادل عائد توزيعات أرباح قدره ١٫٩٢ %.

Carl Zeiss Meditec يُصنف ضمن قطاع 'الصحة'.

لكي تستلم آخر توزيعات أرباح بقيمة ١٫١ EUR من Carl Zeiss Meditec المُعلن عنها في ٢٦‏/٣‏/٢٠٢٤، كان يجب أن تمتلك السهم في محفظتك قبل تاريخ الاستحقاق السابق في ٢٢‏/٣‏/٢٠٢٤.

تم توزيع آخر دفعة من الأرباح بتاريخ ٢٦‏/٣‏/٢٠٢٤.

في العام 2023، وزعت Carl Zeiss Meditec ٠٫٩ EUR كأرباح أسهم.

يتم توزيع أرباح Carl Zeiss Meditec بالعملة EUR.